About
Biosimilars, Oral Delivery of Biologics
Areas of Focus
Categories
BiosimilarsDrug Delivery & Formulation
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
148
By Phase
PHASE2: 1PHASE1: 1
By Status
RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06764940Lead Sponsor
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
PHASE2Recruiting
120 participants
Started: Jul 14, 2025 · Completed: Jul 15, 2027
NCT05681000Lead Sponsor
Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors
PHASE1Unknown
28 participants
Started: Jun 9, 2023 · Completed: Dec 31, 2024
Locations (1)
Headquarters
Leiden, Netherlands
Map
Loading map...